The physiological roles of colonic L cells, which contain a large proportion of the body’s endogenous reserves of GLP-1 and PYY, still remain a mystery, but our results indicate they would be good targets for small molecules aiming to increase GLP-1 and PYY release for the treatment of diabetes and obesity. The gene discussed is GLP1R; the disease is obesity disorder.